Rheumatoid arthritis, cognitive impairment, and neuroimaging biomarkers: results from the Mayo Clinic Study of Aging
Manuscript Number:
22-0368R1
Author(s):
Cynthia S. Crowson, John M. Davis III, Stephanie Q. Duong, David T. Jones, Michelle M. Mielke, Elena Myasoedova, Aivi Nguyen, Maria Vassilaki, Prashanthi Vemuri
Disclosures
Cynthia S. Crowson
Nothing to Disclose
John M. Davis III
Patents/Royalties
Patent pending for a metabolic biomarker of disease activity in rheumatoid arthritis
Grants
Agency:
Pfizer
Dates:
2017-2022
Stephanie Q. Duong
Nothing to Disclose
David T. Jones
Nothing to Disclose
Michelle M. Mielke
Consulting Fees:
I have received consulting fees from Biogen, LabCorp, Lilly and Merck
Elena Myasoedova
Nothing to Disclose
Aivi Nguyen
Nothing to Disclose
Maria Vassilaki
Consulting Fees:
Consulting for F. Hoffmann-La Roche on analysis of data and interpretation (2021-2022) and have received a total of $6125; payments are submitted to my institution. No additional consulting fees are expected; continue collaboration until analysis/interpretation is complete.
Equity:
Equity ownership in Abbott Laboratories, Johnson and Johnson, Medtronic, AbbVie, and Amgen